Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence.
Breast Care (Basel)
; 10(1): 44-9, 2015 Feb.
Article
in En
| MEDLINE
| ID: mdl-25960725
ABSTRACT
Radiation therapy delivered with hypofractionation, which involves the delivery of a higher dose per fraction in fewer fractions (generally with a lower total nominal dose) over a shorter overall treatment time, is an established therapeutic option at least for a selected group of early breast cancer patients after breast-conserving surgery. Optimal delivery of the tumor bed boost dose in terms of timing, fractionation, and total dose whenever a hypofractionated schedule is employed has yet to be established. We herein present a review of the current evidence on the role of boost integration in whole breast radiotherapy.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Breast Care (Basel)
Year:
2015
Document type:
Article
Affiliation country:
Italy